Understanding and Managing IEC-HS: A Critical Complication in CAR-T Therapy
Chimeric antigen receptor T-cell (CAR-T) therapy stands as a groundbreaking advancement in the treatment of hematologic malignancies, offering hope and durable remissions for patients with...















